Chun Hang Yu

Annidis Corp. is a holding company, which engages in the research and development of eye care equipment. The firm provides eye-centric products and services that helps eye care professionals screen, detect, diagnose, treat and manage ocular diseases. Its RHA is an ocular pathology management system that integrates advanced multi-spectral imaging and analytic software for early detection and management of ocular pathologies, such as glaucoma, age related macular degeneration and diabetic retinopathy. The company was founded in 2007 and is headquartered in Ottawa, Canada.

Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China.